Literature DB >> 19266292

Semaphorins and tumor angiogenesis.

Guido Serini1, Federica Maione, Enrico Giraudo, Federico Bussolino.   

Abstract

Semaphorins belong to a large family of proteins well-conserved along evolution from viruses to mammalians. Secreted and membrane-bound semaphorins participate in a wide range of biological phenomena including development and regeneration of nervous system, cardiovascular development, and immune system activities. Different classes of semaphorins are bifunctional and often exert opposite effects (i.e., repellent or attractive) by acting through the plexin receptor family. However, some classes use other membrane receptors and the same plexin-mediated signals may be modulated by co-receptors, in particular neuropilins or some tyrosine kinase receptors. In cancer, semaphorins have both tumor-suppressor and tumor-promoting functions, by acting on both tumor and stromal components. Here, we review the role of semaphorins in tumor angiogenesis and propose that an unbalance between autocrine loops respectively involving angiogenic inducers and class 3 semaphorin is instrumental for structural and functional abnormalities observed in tumor vasculature.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19266292     DOI: 10.1007/s10456-009-9138-4

Source DB:  PubMed          Journal:  Angiogenesis        ISSN: 0969-6970            Impact factor:   9.596


  27 in total

Review 1.  Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer.

Authors:  Atsuko Sakurai; Colleen L Doçi; Colleen Doci; J Silvio Gutkind
Journal:  Cell Res       Date:  2011-12-13       Impact factor: 25.617

Review 2.  Regulation of immune cell responses by semaphorins and their receptors.

Authors:  Hyota Takamatsu; Tatsusada Okuno; Atsushi Kumanogoh
Journal:  Cell Mol Immunol       Date:  2010-02-01       Impact factor: 11.530

Review 3.  Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.

Authors:  Prasanta K Hota; Matthias Buck
Journal:  Cell Mol Life Sci       Date:  2012-06-29       Impact factor: 9.261

4.  Semaphorin 5A, an axon guidance molecule, enhances the invasion and metastasis of human gastric cancer through activation of MMP9.

Authors:  Guoqing Pan; Xiangling Zhang; Junyu Ren; Jianbo Lu; Wenliang Li; Hongmei Fu; Shufang Zhang; Jun Li
Journal:  Pathol Oncol Res       Date:  2012-07-21       Impact factor: 3.201

5.  ERK2 is essential for the growth of human epithelioid malignant mesotheliomas.

Authors:  Arti Shukla; Jedd M Hillegass; Maximilian B MacPherson; Stacie L Beuschel; Pamela M Vacek; Kelly J Butnor; Harvey I Pass; Michele Carbone; Joseph R Testa; Nicholas H Heintz; Brooke T Mossman
Journal:  Int J Cancer       Date:  2011-01-06       Impact factor: 7.396

6.  Semaphorin 3A promotes osteogenic differentiation in human alveolar bone marrow mesenchymal stem cells.

Authors:  Li Liu; Jue Wang; Xiaomeng Song; Qingping Zhu; Shuping Shen; Wei Zhang
Journal:  Exp Ther Med       Date:  2018-01-30       Impact factor: 2.447

Review 7.  The role of semaphorins and their receptors in vascular development and cancer.

Authors:  Chenghua Gu; Enrico Giraudo
Journal:  Exp Cell Res       Date:  2013-02-17       Impact factor: 3.905

8.  Vicrostatin - an anti-invasive multi-integrin targeting chimeric disintegrin with tumor anti-angiogenic and pro-apoptotic activities.

Authors:  Radu O Minea; Corey M Helchowski; Samuel J Zidovetzki; Fritz K Costa; Stephen D Swenson; Francis S Markland
Journal:  PLoS One       Date:  2010-06-03       Impact factor: 3.240

9.  Suppressive effects of vascular endothelial growth factor-B on tumor growth in a mouse model of pancreatic neuroendocrine tumorigenesis.

Authors:  Imke Albrecht; Lucie Kopfstein; Karin Strittmatter; Tibor Schomber; Annelie Falkevall; Carolina E Hagberg; Pascal Lorentz; Michael Jeltsch; Kari Alitalo; Ulf Eriksson; Gerhard Christofori; Kristian Pietras
Journal:  PLoS One       Date:  2010-11-24       Impact factor: 3.240

Review 10.  Natural products against cancer angiogenesis.

Authors:  El Bairi Khalid; El-Meghawry El-Kenawy Ayman; Heshu Rahman; Guaadaoui Abdelkarim; Agnieszka Najda
Journal:  Tumour Biol       Date:  2016-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.